19
PAI Pharmaceutical Associates, based in U.S.A, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is CEFTAZIDIME, with a corresponding application number 50578.
Regulatory Information DISCN
With a dosage strength 6GM/VIAL
Dosage Form Route INJECTABLE; INJECTION
Reference Listed Drug Yes
Approved since 1985-07-19
18
PAI Pharmaceutical Associates, based in U.S.A, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is CEFTAZIDIME, with a corresponding application number 50578.
Regulatory Information DISCN
With a dosage strength 1GM/VIAL
Dosage Form Route INJECTABLE; INJECTION
Reference Listed Drug Yes
Approved since 1985-07-19
17
PAI Pharmaceutical Associates, based in U.S.A, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is CEFTAZIDIME, with a corresponding application number 50578.
Regulatory Information DISCN
With a dosage strength 2GM/VIAL
Dosage Form Route INJECTABLE; INJECTION
Reference Listed Drug Yes
Approved since 1985-07-19
16
PAI Pharmaceutical Associates, based in U.S.A, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is CEFTAZIDIME, with a corresponding application number 50578.
Regulatory Information DISCN
With a dosage strength 500MG/VIAL
Dosage Form Route INJECTABLE; INJECTION
Reference Listed Drug Yes
Approved since 1985-07-19